ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Profit from the Pros – Zacks Free Email Newsletter
Our free email newsletter is filled with timely stock picks and market commentary. Sign up for free. Already on board? Check out the archive.

Quote:

Search for Ticker

Free Membership

Search:

CSKI: China Sky One Medical Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

CHINA SKY ONE MEDICAL INC (NASD)
CSKI	17.37	-0.07	(-0.40%)	Vol. 16,101	10:18 ET

CHINA SKY ONE MEDICAL Inc a Nevada corporation, is a holding company whose principal operations are through its subsidiaries, which are engaged in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic kit products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company (TDR) and Harbin First Bio-Engineering Company Limited (First),

General Information

CHINA SKY ONE

No 38 Dingxin 3rd Street Nangang District Harbin, - 150001 Phone: 86 451 5399 4073 Fax: - Web: www.skyonemedical.com Email: ir@skyonemedical.com

Industry	MED-DRUGS
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	12/31/09
Next EPS Date	04/15/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	17.44
52 Week High	25.45
52 Week Low	10.03
Beta	0.98
20 Day Moving Average	258,495.75
Target Price Consensus	26.25

% Price Change
4 Week	-19.00
12 Week	13.25
YTD	-23.34

% Price Change Relative to S&P 500
4 Week	-14.02
12 Week	17.46
YTD	-21.57

Share Information
Shares Outstanding (millions)	16.66
Market Capitalization (millions)	290.57
Short Ratio	4.49
Last Split Date	N/A

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.52
Current Year EPS Consensus Estimate	2.27
Estimated Long-Term EPS Growth Rate	-
Next EPS Report Date	04/15/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	1.00
30 Days Ago	1.00
60 Days Ago	1.00
90 Days Ago	1.00

Fundamental Ratios

P/E
Current FY Estimate:	6.63
Trailing 12 Months:	7.96
PEG Ratio	-

EPS Growth
vs. Previous Year	23.33%
vs. Previous Quarter	29.82%

Sales Growth
vs. Previous Year	45.55%
vs. Previous Quarter:	34.32%

Price Ratios
Price/Book	2.34
Price/Cash Flow	-
Price / Sales	-

ROE
12/31/09	-
09/30/09	29.03
06/30/09	39.09

ROA
12/31/09	-
09/30/09	26.34
06/30/09	35.35

Current Ratio
12/31/09	-
09/30/09	7.24
06/30/09	-

Quick Ratio
12/31/09	-
09/30/09	7.00
06/30/09	-

Operating Margin
12/31/09	-
09/30/09	28.60
06/30/09	29.81

Net Margin
12/31/09	-
09/30/09	-
06/30/09	-

Pre-Tax Margin
12/31/09	-
09/30/09	-
06/30/09	-

Book Value
12/31/09	-
09/30/09	7.47
06/30/09	-

Inventory Turnover
12/31/09	-
09/30/09	-
06/30/09	-

Debt-to-Equity
12/31/09	-
09/30/09	0.00
06/30/09	-

Debt to Capital
12/31/09	-
09/30/09	0.00
06/30/09	-


About Zacks \| Advertise \| Affiliate \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2010 Zacks Investment Research